Keith R. Leonard, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 39,272 shares at $25.39 ($997K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($997k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |
| SNNA | BUY | 2017-08-01 | $251K | — | Filing → |